Aakash Rajwani
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,173 | 156 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $448.79 | 22 | $0 (2024) |
| Novo Nordisk Inc | $426.20 | 22 | $0 (2024) |
| Lilly USA, LLC | $339.60 | 18 | $0 (2024) |
| ABBVIE INC. | $279.41 | 17 | $0 (2024) |
| Amgen Inc. | $239.92 | 8 | $0 (2024) |
| PFIZER INC. | $160.03 | 8 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $138.16 | 8 | $0 (2024) |
| Amneal Pharmaceuticals LLC | $135.55 | 8 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $124.93 | 1 | $0 (2023) |
| Insulet Corporation | $105.31 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,464 | 72 | Novo Nordisk Inc ($327.11) |
| 2023 | $1,490 | 72 | Bayer Healthcare Pharmaceuticals Inc. ($322.52) |
| 2022 | $219.21 | 12 | Bayer HealthCare Pharmaceuticals Inc. ($94.31) |
All Payment Transactions
156 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Diabetes | ||||||
| 12/16/2024 | PFIZER INC. | SOMAVERT (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: ENDOCRINE DISEASE;METABOLIC DISEASE | ||||||
| 12/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $30.72 | General |
| Category: Diabetes | ||||||
| 12/09/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $109.75 | General |
| Category: Bone Health | ||||||
| 12/03/2024 | Almatica Pharma LLC | TERIPARATIDE (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: OSTEOPOROSIS | ||||||
| 11/26/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $16.18 | General |
| 11/25/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $25.43 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | PFIZER INC. | SOMAVERT (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: ENDOCRINE DISEASE;METABOLIC DISEASE | ||||||
| 11/08/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/05/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: DIABETES MEDICINE | ||||||
| 10/29/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $14.47 | General |
| 10/24/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: Bone Health | ||||||
| 10/16/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $29.03 | General |
| Category: Endocrinology | ||||||
| 10/15/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/11/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.18 | General |
| Category: Diabetes | ||||||
| 10/07/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/04/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Diabetes | ||||||
| 09/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: DIABETES | ||||||
| 09/26/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $15.16 | General |
| 09/17/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 158 | 192 | $80,271 | $22,751 |
| 2022 | 2 | 48 | 48 | $24,208 | $6,791 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 35 | 64 | $20,096 | $7,226 | 36.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 46 | 46 | $22,402 | $6,728 | 30.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 46 | 46 | $23,874 | $5,451 | 22.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 15 | 15 | $7,305 | $1,719 | 23.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 16 | 21 | $6,594 | $1,626 | 24.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $10,714 | $3,514 | 32.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 26 | 26 | $13,494 | $3,277 | 24.3% |
About Aakash Rajwani
Aakash Rajwani is a Student in an Organized Health Care Education/Training Program healthcare provider based in Staten Island, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2018. The National Provider Identifier (NPI) number assigned to this provider is 1003392192.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Aakash Rajwani has received a total of $3,173 in payments from pharmaceutical and medical device companies, with $1,464 received in 2024. These payments were reported across 156 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($3,173).
As a Medicare-enrolled provider, Rajwani has provided services to 206 Medicare beneficiaries, totaling 240 services with total Medicare billing of $29,542. Data is available for 2 years (2022–2023), covering 7 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Diabetes & Metabolism
- Location Staten Island, NY
- Active Since 07/12/2018
- Last Updated 12/04/2022
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1003392192
Products in Payments
- Kerendia (Drug) $448.79
- Ozempic (Drug) $240.18
- SYNTHROID (Drug) $202.57
- EVENITY (Biological) $170.40
- SOMAVERT (Drug) $160.03
- MOUNJARO (Drug) $155.17
- Rybelsus (Drug) $144.13
- TZIELD (Biological) $138.16
- UNITHROID (Drug) $135.55
- JARDIANCE (Drug) $125.49
- ELIQUIS (Drug) $124.93
- Omnipod (Device) $105.31
- MYCAPSSA (Drug) $74.61
- TEPEZZA (Biological) $69.52
- FARXIGA (Drug) $67.93
- AFREZZA (Drug) $60.78
- Tymlos (Drug) $59.64
- JATENZO (Drug) $51.92
- LICART (Drug) $50.93
- BD Nano 2nd Gen Pen Needle (Device) $43.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Staten Island
Dr. Elizabeth Lulaj, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $47,200
Dr. Samer Saouma, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $31,327
Dr. Philippe Akhrass, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $14,172
Gledi Peco, Dpm, DPM
Student in an Organized Health Care Education/Training Program — Payments: $7,295
Anna Nemeth
Student in an Organized Health Care Education/Training Program — Payments: $3,847
Chadi Salmane
Student in an Organized Health Care Education/Training Program — Payments: $3,597